000 01585 a2200421 4500
005 20250512194804.0
264 0 _c19850319
008 198503s 0 0 eng d
022 _a0167-8140
024 7 _a10.1016/s0167-8140(84)80077-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWike-Hooley, J L
245 0 0 _aThe relevance of tumour pH to the treatment of malignant disease.
_h[electronic resource]
260 _bRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_cDec 1984
300 _a343-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBicarbonates
_xtherapeutic use
650 0 4 _aCell Line
650 0 4 _aCell Survival
_xradiation effects
650 0 4 _aCombined Modality Therapy
650 0 4 _aCricetinae
650 0 4 _aGlucose
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aHyperthermia, Induced
650 0 4 _aMice
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aRadiation-Sensitizing Agents
_xtherapeutic use
650 0 4 _aRats
650 0 4 _aReference Values
650 0 4 _aSodium Bicarbonate
700 1 _aHaveman, J
700 1 _aReinhold, H S
773 0 _tRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_gvol. 2
_gno. 4
_gp. 343-66
856 4 0 _uhttps://doi.org/10.1016/s0167-8140(84)80077-8
_zAvailable from publisher's website
999 _c6098049
_d6098049